Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Stock Forecast

Stock Price Forecast

The 21 analysts that cover Neurocrine Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $177.14, which forecasts a 30.66% increase in the stock price over the next year. The lowest target is $115 and the highest is $203.

Price Target: $177.14 (+30.66%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$115	$177.14	$179	$203
Change	-15.17%	+30.66%	+32.04%	+49.74%

Analyst Ratings

The average analyst rating for Neurocrine Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	10	9	10	10	12	12
Buy	9	8	8	8	8	6
Hold	1	1	1	1	2	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	18	19	19	22	21

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Danielle Brill Truist Securities	Truist Securities	Strong Buy Maintains $172 → $169	Strong Buy	Maintains	$172 → $169	+24.66%	Jan 8, 2026
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy → Hold Downgrades $173 → $175	Buy → Hold	Downgrades	$173 → $175	+29.08%	Jan 8, 2026
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $168 → $198	Strong Buy	Maintains	$168 → $198	+46.05%	Dec 17, 2025
Uy Ear Mizuho	Mizuho	Hold Maintains $146 → $175	Hold	Maintains	$146 → $175	+29.08%	Dec 12, 2025
Paul Matteis Stifel	Stifel	Strong Buy Maintains $183 → $188	Strong Buy	Maintains	$183 → $188	+38.67%	Dec 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.91B

Increased by 23.68%

from 2.36B

Revenue Next Year

3.45B

Increased by 18.47%

from 2.91B

EPS This Year

5.13

Increased by 55.94%

from 3.29

EPS Next Year

7.20

Increased by 40.43%

from 5.13

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.05B	1.13B	1.49B	1.89B	2.36B	2.91B	3.45B
Revenue Growth	32.71%	8.38%	31.34%	26.76%	24.81%	23.68%	18.47%
EPS	4.16	0.92	1.56	2.47	3.29	5.13	7.20
EPS Growth	966.67%	-77.89%	69.57%	58.33%	33.20%	55.94%	40.43%
Forward PE	-	-	-	-	-	26.42	18.82
No. Analysts	-	-	-	-	-	30	29

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	3.0B	3.8B
Avg	2.9B	3.5B
Low	2.7B	3.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	28.6%	31.5%
Avg	23.7%	18.5%
Low	16.5%	4.5%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	5.82	9.64
Avg	5.13	7.20
Low	4.46	3.55

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	76.8%	87.9%
Avg	55.9%	40.4%
Low	35.5%	-30.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.